On June 12, Praxis Precision Medicines rose 5.02% in regular trading, trading at $249.57/share, with turnover of $48.332 million.
Within the Biotechnology sector where Praxis Precision Medicines belongs, notable movers include Amgen up 4.98%, Propanc Biopharma up 128.21%, Nuvalent up 0.02%, AbbVie up 0.49%, and Gilead Sciences up 4.33%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)